11,373 Shares in The Clorox Company $CLX Purchased by Northwestern Mutual Wealth Management Co.

Key Points

• Northwestern Mutual Wealth Management acquired 11,373 Clorox shares worth approximately $1.085 million, while institutional investors collectively own 78.53% of the company.
• Wall Street sentiment remains cautious: 12 analysts rate Clorox a Hold and five rate it a Sell, producing a consensus rating of “Reduce” and an average price target of $102.40.
• Clorox slightly exceeded quarterly earnings and revenue expectations, but revenue declined 2% year over year. The company raised its quarterly dividend to $1.25, implying a 4.8% annual yield, despite a payout ratio above 100%.

Northwestern Mutual Wealth Management Co. acquired a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 11,373 shares of the company's stock, valued at approximately $1,085,000.

Other hedge funds also recently modified their holdings of the company. Wilkins Investment Counsel Inc. boosted its stake in Clorox by 250.6% during the 4th quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company's stock worth $5,552,000 after acquiring an additional 39,360 shares during the last quarter. Morningstar Investment Management LLC increased its stake in Clorox by 131.8% in the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company's stock valued at $6,297,000 after purchasing an additional 35,506 shares in the last quarter. Bank of America Corp DE increased its stake in Clorox by 6.1% in the first quarter. Bank of America Corp DE now owns 1,405,774 shares of the company's stock valued at $145,680,000 after purchasing an additional 80,618 shares in the last quarter. National Pension Service raised its holdings in Clorox by 68.9% in the fourth quarter. National Pension Service now owns 27,537 shares of the company's stock worth $2,777,000 after purchasing an additional 11,233 shares during the period. Finally, Ilmarinen Mutual Pension Insurance Co bought a new position in shares of Clorox during the fourth quarter worth $1,966,000. Institutional investors own 78.53% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on CLX. UBS Group raised their price objective on Clorox from $100.00 to $105.00 and gave the stock a "neutral" rating in a research note on Tuesday, August 4th. Morgan Stanley lowered their price target on Clorox from $110.00 to $97.00 and set an "equal weight" rating for the company in a report on Friday, May 1st. Citigroup raised their price target on Clorox from $97.00 to $100.00 and gave the stock a "neutral" rating in a research report on Tuesday, August 4th. BNP Paribas Exane cut their price objective on Clorox from $97.00 to $95.00 and set a "neutral" rating on the stock in a report on Monday, July 20th. Finally, Barclays reiterated an "underweight" rating and issued a $84.00 price objective on shares of Clorox in a research report on Tuesday, August 4th. Twelve equities research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company's stock. According to data from MarketBeat.com, Clorox currently has a consensus rating of "Reduce" and a consensus price target of $102.40.

Clorox Price Performance

Shares of NYSE CLX opened at $105.08 on Wednesday. The firm has a market cap of $12.71 billion, a PE ratio of 21.80, a PEG ratio of 3.35 and a beta of 0.54. The company has a current ratio of 0.66, a quick ratio of 0.38 and a debt-to-equity ratio of 15.80. The Clorox Company has a 1-year low of $84.70 and a 1-year high of $128.90. The company has a fifty day moving average price of $99.35 and a 200 day moving average price of $102.92.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.02. The firm had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.91 billion. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The company's revenue for the quarter was down 2.0% on a year-over-year basis. During the same quarter last year, the business posted $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Research analysts predict that The Clorox Company will post 5.8 earnings per share for the current fiscal year.

Clorox Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Wednesday, August 12th will be given a $1.25 dividend. The ex-dividend date of this dividend is Wednesday, August 12th. This represents a $5.00 dividend on an annualized basis and a yield of 4.8%. This is a boost from Clorox's previous quarterly dividend of $1.24. Clorox's payout ratio is 103.73%.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source